- This article may be of interest to you as I am sure we
are all concerned as to what our children are being, injected with, as
responsible parents and grand-parents there is a NEED TO KNOW. Rather
frightening don't you think? No wonder the Prime Minister of England refused
to have his child immunised... ___
- One hundred years ago, children received 1 vaccine (the
smallpox vaccine). Forty years ago, children received 5 vaccines routinely
(diphtheria, pertussis, tetanus, polio, and smallpox vaccines) and as
many as 8 shots by 2 years of age.
- Children now receive 52 vaccines, in the form of 15
shots, by the time they are 6 months of age if they receive all the recommend
shots, including the Prevnar pediatric pneumonia shot.
- Vaccines contain THIMERSOL (mercury), MSG, aluminum,
formaldehyde, sucrose and phenoxyethanol, which is antifreeze, among many
- Thimerosal, a vaccine ingredient, is nearly 50% mercury.
- Mercury is a NEUROTOXIN.
- EPA 'safe' levels are: .1 microgram per 1.0 kilogram
of body weight per day.
- Vaccines contain 12.5 to 25.0 micrograms of mercury,
and a 'well baby' visit can see your child have between 50 and 62.5 mcgs
of MERCURY injected into their bloodstream.
- The CDC (US) has found a trend linking autism to mercury
- Thimerosal is a registered pesticide with the Department
of Pesticide Registration of the Environmental Protection Agency.
- Vaccines given:
- Day of Birth: Hepatitis B Contains 12 mcg mercury which
is 30 times above the 'safe' level
- At 4 Months: DTaP and HiB on same day These contain
50 mcg mercury which is 60 times above the 'safe' level
- At 6 Months: Hep B, Polio These contain 62.5 mcg mercury
which is 78 times above the 'safe' level
- At 15 Months, the child receives another 50 mcg mercury
which is 41 times above the 'safe' level.
- Low levels of mercury during critical stages of development
have been associated with neurological disorders in children including
ADD learning difficulties, Autism and speech delays.
- Wonder why we have an epidemic of these conditions? As
of 2001, up to twenty-four vaccines are recommended from birth to eighteen
- This schedule indicates the recommended ages for routine
administration of currently licensed childhood vaccines, as of December
1, 2001, for children through age 18 years. Any dose not given at the
recommended age should be given at any subsequent visit when indicated
- 1. Hepatitis B vaccine (Hep B). All infants should receive
the first dose of hepatitis B vaccine soon after birth and before hospital
discharge; the first dose may also be given by age 2 months if the infant,s
mother is HBsAg-negative. Only monovalent hepatitis B vaccine can be used
for the birth dose. Monovalent or combination vaccine containing Hep B
may be used to complete the series; four doses of vaccine may be administered
if combination vaccine is used. The second dose should be given at least
4 weeks after the first dose, except for Hib-containing vaccine which
cannot be administered before age 6 weeks. The third dose should be given
at least 16 weeks after the first dose and at least 8 weeks after the
second dose. The last dose in the vaccination series (third or fourth
dose) should not be administered before age 6 months.
- Infants born to HBsAg-positive mothers should receive
hepatitis B vaccine and 0.5 mL hepatitis B immune globulin (HBIG) within
12 hours of birth at separate sites. The second dose is recommended at
age 1-2 months and the vaccination series should be completed (third or
fourth dose) at age 6 months.
- Infants born to mothers whose HBsAg status is unknown
should receive the first dose of the hepatitis B vaccine series within
12 hours of birth. Maternal blood should be drawn at the time of delivery
to determine the mother,s HBsAg status; if the HBsAg test is positive,
the infant should receive HBIG as soon as possible (no later than age
- 2. Diphtheria and tetanus toxoids and acellular pertussis
vaccine (DTaP). The fourth dose of DTaP may be administered as early as
age 12 months, provided 6 months have elapsed since the third dose and
the child is unlikely to return at age 15-18 months. Tetanus and diphtheria
toxoids (Td) is recommended at age 11-12 years if at least 5 years have
elapsed since the last dose of tetanus and diphtheria toxoid-containing
vaccine. Subsequent routine Td boosters are recommended every 10 years.
- 3. Haemophilus influenzae type b (Hib) conjugate vaccine.
Three Hib conjugate vaccines are licensed for infant use. If PRP-OMP (PedvaxHIB
® or ComVax ® [Merck]) is administered at ages 2 and 4 months,
a dose at age 6 months is not required. DTaP/Hib combination products
should not be used for primary immunization in infants at ages 2, 4 or
6 months, but can be used as boosters following any Hib vaccine.
- 4. Inactivated polio vaccine (IPV). An all-IPV schedule
is recommended for routine childhood polio vaccination in the United States.
All children should receive four doses of IPV at ages 2 months, 4 months,
6-18 months, and 4-6 years.
- 5. Measles, mumps, and rubella vaccine (MMR). The second
dose of MMR is recommended routinely at age 4-6 years but may be administered
during any visit, provided at least 4 weeks have elapsed since the first
dose and that both doses are administered beginning at or after age 12
months. Those who have not previously received the second dose should
complete the schedule by the 11-12 year old visit.
- 6. Varicella vaccine. Varicella vaccine is recommended
at any visit at or after age 12 months for susceptible children, i.e.
those who lack a reliable history of chickenpox. Susceptible persons aged
>13 years should receive two doses, given at least 4 weeks apart.
- 7. Pneumococcal vaccine. The heptavalent pneumococcal
conjugate vaccine (PCV) is recommended for all children age 2-23 months.
It is also recommended for certain children age 24-59 months. Pneumococcal
polysaccharide vaccine (PPV) is recommended in addition to PCV for certain
high-risk groups. See MMWR. 2000;49(RR-9):1-35.
- 8. Hepatitis A vaccine. Hepatitis A vaccine is recommended
for use in selected states and regions, and for certain high-risk groups;
consult your local public health authority. See MMWR. 1999;48(RR-12):1-37.
- 9. Influenza vaccine. Influenza vaccine is recommended
annually for children age > 6 months with certain risk factors (including
but not limited to asthma, cardiac disease, sickle cell disease, HIV,
diabetes; see MMWR. 2001;50(RR-4):1- 44), and can be administered to all
others wishing to obtain immunity. Children aged <12 years should receive
vaccine in a dosage appropriate for their age (0.25 mL if age 6-35 months
or 0.5 mL if age >3 years). Children aged <8 years who are receiving
influenza vaccine for the first time should receive two doses separated
by at least 4 weeks.
- For additional information about vaccines, vaccine supply,
and contraindications for immunization, please visit the National Immunization
Program Web site at www.cdc.gov/nip or call the National Immunization
Hotline at (800) 232-2522 (English) or (800) 232-0233 (Spanish).